1naresh
Array ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) ) 1nareshArray ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) )Table 3:Locations and imaging appearance of cervical lymph node spreada
Lymph Nodes No. of Patients (%) Location (n = 14) Level I 8 (57) Level II 13 (93) Level III 7 (50) Level IV 1 (7) Level V 3 (21) Level VI 0 (0) Level VII 0 (0) RPN 6 (43) General appearance on CT (n = 14) Completely cystic (no solid areas on CT) 0 (0) Predominantly cystic (<25% solid in appearance) 1 (7) Moderately cystic (25%–49% solid) 0 (0) Moderately solid (50%–74% solid) 0 (0) Predominantly solid (75%–99%) 4 (29) Completely solid (100% solid) 9 (64) Degree of contrast enhancement on CT (n = 14) None (no enhancing tissue visualized) 0 (0) Mild (similar in density to normal lymph nodes) 1 (7) Moderate (similar in density to glandular tissue) 7 (50) Maximal (similar in density to vessels) 6 (43) FDG avidity (n = 12) Low 3 (25) Medium 5 (42) High 4 (33)
a Metastases to level II lymph nodes occur in almost all patients with cervical disease. Levels I and III occur in >50% of patients, while RPNs are present in 43% of patients. On imaging, metastatic cervical lymph nodes are predominantly solid, with moderate-to-maximal contrast enhancement and medium-to-high FDG avidity.